Ocunexus Therapeutics, Inc.
🇺🇸United States
A Study to Investigate the Safety and Clinical Effect of Nexagon® as a Topical Treatment for Subjects With a Diabetic Foot Ulcer (DUNE)
Phase 2
Completed
- Conditions
- Diabetic Foot Ulcers
- Interventions
- First Posted Date
- 2011-12-13
- Last Posted Date
- 2014-05-01
- Lead Sponsor
- OcuNexus Therapeutics, Inc.
- Target Recruit Count
- 168
- Registration Number
- NCT01490879
- Locations
- 🇺🇸
Advanced Foot Care and Clinical Research Center, Fresno, California, United States
🇺🇸Doctors Research Network, South Miami, Florida, United States
🇺🇸Advanced Foot and Ankle Center, Las Vegas, Nevada, United States
A Study to Investigate the Efficacy, Safety and Tolerability of Nexagon® as a Topical Treatment for Subjects With Venous Leg Ulcers
Phase 2
Completed
- Conditions
- Venous Leg Ulcers
- Interventions
- First Posted Date
- 2010-09-13
- Last Posted Date
- 2014-05-01
- Lead Sponsor
- OcuNexus Therapeutics, Inc.
- Target Recruit Count
- 300
- Registration Number
- NCT01199588
- Locations
- 🇺🇸
Southern Arizona Limb Salvage Alliance, Tucson, Arizona, United States
🇺🇸St Luke's - Roosevelt Hospital Center Department of Surgery, New York, New York, United States
🇺🇸Stonybrook Univeristy Medical Center, New York, New York, United States
A Study to Investigate the Safety and Clinical Effect of Nexagon® to Treat Persistent Epithelial Defects
Phase 2
Withdrawn
- Conditions
- Persistent Epithelial Defect
- First Posted Date
- 2009-01-13
- Last Posted Date
- 2010-02-26
- Lead Sponsor
- OcuNexus Therapeutics, Inc.
- Target Recruit Count
- 90
- Registration Number
- NCT00821561
A Trial to Assess the Safety and Activity of Nexagon® for the Treatment of Venous Leg Ulcers (The NOVEL Study)
Phase 2
Completed
- Conditions
- Venous Ulcer
- First Posted Date
- 2009-01-12
- Last Posted Date
- 2012-09-18
- Lead Sponsor
- OcuNexus Therapeutics, Inc.
- Target Recruit Count
- 98
- Registration Number
- NCT00820196
- Locations
- 🇳🇿
Dunedin Hosptial, Dunedin, New Zealand
🇳🇿Home Health Services Papakura, Auckland, New Zealand
🇳🇿Waikato Hospital, Hamilton, New Zealand
The ASCEND Study: A Study to Investigate the Safety and Clinical Effect of Nexagon to Treat Slow Healing Diabetic Foot Ulcers
Phase 1
Terminated
- Conditions
- Diabetic Foot Ulcer
- First Posted Date
- 2009-01-12
- Last Posted Date
- 2010-08-31
- Lead Sponsor
- OcuNexus Therapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00820703
- Locations
- 🇳🇿
Middlemore Hospital, Auckland, New Zealand
A Study Evaluating Nexagon™ in the Treatment of Skin Wounds.
Phase 1
Completed
- Conditions
- Wound Healing
- Interventions
- Drug: Nexagon™ or Nexagon™ vehicle
- First Posted Date
- 2008-08-18
- Last Posted Date
- 2009-04-27
- Lead Sponsor
- OcuNexus Therapeutics, Inc.
- Target Recruit Count
- 43
- Registration Number
- NCT00736593
- Locations
- 🇳🇿
Auckland Clinical Studies, Auckland, New Zealand
A Study to Assess the Safety, Tolerability and Effect of Nexagon™ Applied to the Eye After PRK Laser Eye Surgery for Nearsightedness
Phase 1
Completed
- Conditions
- Corneal re-Epithelialization
- Interventions
- Drug: Nexagon™ or Nexagon™ vehicle
- First Posted Date
- 2008-04-08
- Last Posted Date
- 2009-01-08
- Lead Sponsor
- OcuNexus Therapeutics, Inc.
- Target Recruit Count
- 24
- Registration Number
- NCT00654550
- Locations
- 🇳🇿
Auckland Eye Limited, Auckland, New Zealand
© Copyright 2025. All Rights Reserved by MedPath